Thermo Fisher Scientific Inc. (TMO)
- Previous Close
577.39 - Open
577.40 - Bid 572.43 x 800
- Ask 572.98 x 800
- Day's Range
569.98 - 577.99 - 52 Week Range
415.60 - 603.82 - Volume
554,139 - Avg. Volume
1,460,758 - Market Cap (intraday)
218.816B - Beta (5Y Monthly) 0.80
- PE Ratio (TTM)
37.06 - EPS (TTM)
15.47 - Earnings Date Jul 24, 2024 - Jul 29, 2024
- Forward Dividend & Yield 1.56 (0.27%)
- Ex-Dividend Date Mar 14, 2024
- 1y Target Est
613.15
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
www.thermofisher.com122,000
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: TMO
Performance Overview: TMO
Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: TMO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: TMO
Valuation Measures
Market Cap
220.40B
Enterprise Value
247.24B
Trailing P/E
37.37
Forward P/E
26.81
PEG Ratio (5yr expected)
2.88
Price/Sales (ttm)
5.23
Price/Book (mrq)
4.72
Enterprise Value/Revenue
5.77
Enterprise Value/EBITDA
22.32
Financial Highlights
Profitability and Income Statement
Profit Margin
14.20%
Return on Assets (ttm)
4.82%
Return on Equity (ttm)
13.62%
Revenue (ttm)
42.49B
Net Income Avi to Common (ttm)
6.03B
Diluted EPS (ttm)
15.47
Balance Sheet and Cash Flow
Total Cash (mrq)
7.25B
Total Debt/Equity (mrq)
78.05%
Levered Free Cash Flow (ttm)
6.08B
Research Analysis: TMO
Company Insights: TMO
Fair Value
Dividend Score
Hiring Score
Insider Sentiment Score
Research Reports: TMO
Analyst Report: Thermo Fisher Scientific Inc.
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of mid-2023 (revenue figures include some cross-segment revenue): analytical technologies (16% of sales); specialty diagnostic products (10%); life science solutions (24%); and lab products and services, which includes CRO services (54%).
RatingPrice TargetWeekly Stock List
We see what we believe are some great opportunities right now in Healthcare -- and we like the sector overall. Argus Director of Research Jim Kelleher, CFA, recently completed his quarterly sector review and raised Healthcare sector to Over-Weight from Market-Weight. The healthcare environment is undergoing rapid transitions, and we now see an unfolding period of significant promise and opportunity. Our newly-favored stance is based on resumption of deferred medical procedures and significant new quality-of-life drugs and treatments. The category is broad and has underperformed the S&P 500 over the past year. The Healthcare sector ETF (XLV) is up 15% over the past year compared to a gain of 31% for the S&P 500. We see opportunity here to pick up some steady companies, with big brands and solid financials. These companies are science-focused and enhance lives. They are innovators. In our list this week, we look across several subsectors within the Healthcare sector and pull out some leaders we like. These stocks also are included in our Focus List and Model Portfolios, as noted below.
Analyst Report: Thermo Fisher Scientific Inc.
Thermo Fisher manufactures scientific instruments, consumables, and chemicals. It provides analytical instruments, lab equipment, software reagents, and supplies to pharmaceutical companies, hospitals, clinical diagnostic labs, universities, research institutions, and government agencies.
RatingPrice TargetMarket Update: NI, SON, TMO, W
U.S. markets were mixed on Friday intraday following yesterday's rally. Recent comments from Fed officials indicate that the timing of the first interest rate is likely to come later rather than sooner. On the earnings front, shares of Carvana (CVNA) are up 33% after reported its first profitable year. The Nasdaq fell 0.1%, the S&P 500 was up 0.13% and the Dow gained 0.3%. Crude oil fell $2 to $76.55 per barrel, while gold rose $17 to $2048 per ounce.